ISIS PHARMACEUTICALS INC
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: ISIS PHARMACEUTICALS INC, 10-Q, 2000-11-14
Next: CURATIVE HEALTH SERVICES INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONDENSED BALANCE SHEET AS OF SEPTEMBER 30, 2000 (UNAUDITED) AND
CONDENSED STATEMENTS OF OPERATIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2000
(UNAUDITED) AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          59,030
<SECURITIES>                                    61,655
<RECEIVABLES>                                    6,942
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               128,772
<PP&E>                                          53,345
<DEPRECIATION>                                (30,023)
<TOTAL-ASSETS>                                 176,575
<CURRENT-LIABILITIES>                           14,280
<BONDS>                                         96,330
                                0
                                     24,938
<COMMON>                                            38
<OTHER-SE>                                      40,989
<TOTAL-LIABILITY-AND-EQUITY>                   176,575
<SALES>                                              0
<TOTAL-REVENUES>                                29,319
<CGS>                                                0
<TOTAL-COSTS>                                   50,492
<OTHER-EXPENSES>                                12,646
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               4,464
<INCOME-PRETAX>                               (38,936)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (38,936)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (38,936)
<EPS-BASIC>                                     (1.08)
<EPS-DILUTED>                                   36,172


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission